HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

PF-06652474

a DcpS inhibitor; structure in first source

Also Known As:

D156844

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - PF-06652474: 2

Experts

1.	Butchbach, Matthew E R: 2 articles (09/2015 - 06/2014)
2.	Harris, Ashlee W: 1 article (09/2015)
3.	Burghes, Arthur H M: 1 article (06/2014)
4.	Gurney, Mark E: 1 article (06/2014)
5.	Singh, Jasbir: 1 article (06/2014)

Related Diseases

1.	Disease Progression 09/01/2015 - "In the present study, the effect of a combination regimen of the SMN2 inducer D156844 and the protectant follistatin on the disease progression and survival was measured in the SMNΔ7 SMA mouse model. "
2.	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 06/01/2014 - "The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice." 09/01/2015 - "The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy."

Related Drugs and Biologics

1.	Follistatin